ClinVar Miner

Submissions for variant NM_000090.4(COL3A1):c.3518G>A (p.Gly1173Glu)

dbSNP: rs121912918
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000018757 SCV000938015 likely pathogenic Ehlers-Danlos syndrome, type 4 2018-10-16 criteria provided, single submitter clinical testing Glycine residues within the Gly-Xaa-Yaa repeats of the triple helix domain are required for the structure and stability of fibrillar collagens (PMID: 7695699, 8218237, 19344236). In COL3A1, missense variants at these glycine residues are significantly enriched in individuals with disease (PMID: 24922459, 25758994) compared to the general population (ExAC). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant has been observed in several individuals affected with Ehlers-Danlos syndrome or with clinical features of this disease (PMID: 1357232, 24922459, 10923041). This variant is also known as Gly1006Glu in the literature. ClinVar contains an entry for this variant (Variation ID: 17217). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glycine with glutamic acid at codon 1173 of the COL3A1 protein (p.Gly1173Glu). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and glutamic acid.
OMIM RCV000018757 SCV000039040 pathogenic Ehlers-Danlos syndrome, type 4 1992-01-01 no assertion criteria provided literature only
Collagen Diagnostic Laboratory, University of Washington RCV000018757 SCV000120230 pathogenic Ehlers-Danlos syndrome, type 4 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.